We’ve postured that Resmed has fundamentally changed the US business model in its favour with its Airsense platform. After the release of Resmed’s second quarter results for financial year 2017, we explore how it is tracking against this thesis. continue…

by Ben MacNevin Posted in Health Care

• 2 Comments
• save this article
• POSTED IN Health Care

Privatisation of public health services is often met with fierce criticism (co-payments or ‘Mediscare’ anyone?). But positive feedback for Sydney’s Northern Beaches Hospital has allowed the NSW Government to push ahead with a hospital model that could benefit all stakeholders, including private healthcare operators. continue…

by Ben MacNevin Posted in Health Care

• save this article
• POSTED IN Health Care

As any adherent to professional value investing will attest, the practice in Australia has been challenging in 2016.  For a length of time that we’d prefer not to dwell on, we have rued the broad lack of opportunities.  As a result, Montgomery portfolios have not been fully invested, even as our funds have grown.

by Roger Montgomery Posted in Health Care

• 24 Comments
• save this article
• POSTED IN Health Care

Each year, health care spending chews up an increasingly large chunk of state and federal budgets. This trend is clearly unsustainable. Which is why the Australian government is conducting multiple reviews of the system in the hope of providing more efficient and cheaper care.  So, should we put our faith in the efficacy of these reviews?

continue…

by Ben MacNevin Posted in Health Care

• 3 Comments
• save this article
• POSTED IN Health Care

One year ago this week we reviewed Valeant Pharmaceuticals. Specifically, we revealed that sell side research analysts had remained collectively positive on the prospects of the stock even as the share price was nose-diving as difficulties for the business and its managers were becoming apparent. Fast forward one year. The stock price has been decimated, and only now has the collective call of the Street turned to a sell. Too little too late. But definitely not the first nor the last.

continue…

by Christopher Demasi Posted in Companies, Health Care

• save this article
• POSTED IN Companies, Health Care

Last month, Healthscope (ASX:HSO) announced it had experienced slower-than-expected hospital revenue growth for the quarter.  The announcement prompted a wave of selling, with the share price falling around 30%.  Does this present a buying opportunity?  Given the metrics of the private hospital industry, we think so.

by Roger Montgomery Posted in Health Care, Stocks We Like

• 11 Comments
• save this article
• POSTED IN Health Care, Stocks We Like

When the share price of Healthscope plunged 30% in October, we received numerous queries from many of our thousands of investors and readers.  In short, they were asking: after a price dive like that, what did we think about the business now? continue…

by Roger Montgomery Posted in Editor's Pick, Health Care

• 14 Comments
• save this article
• POSTED IN Editor's Pick, Health Care

The Australian Government has announced it will cut the cost of thousands of medical devices, from pacemakers and lenses to knees and hips. It claims its prostheses price reform will “take pressure off private health insurance premiums”. But looking behind the numbers, it’s hard to get too excited. continue…

by Ben MacNevin Posted in Health Care

• save this article
• POSTED IN Health Care

Sirtex Medical (ASX: SRX) has just reported its FY16 results, and they were pleasing on every metric. We recently commented on the firm’s sales growth which the market took the news badly and subsequently the price of the firm’s shares fell. continue…

by Scott Shuttleworth Posted in Health Care

• 13 Comments
• save this article
• POSTED IN Health Care

ResMed is a business we like. Our positive view of the company was reinforced when ResMed last week released a robust result for the fourth quarter of FY16. Its acquisition of cloud-based health solutions provider, Brightree, could produce an even stronger outlook. continue…

by Ben MacNevin Posted in Companies, Health Care

• save this article
• POSTED IN Companies, Health Care